Expert Consensus on the Clinical Use of Skin Boosters: A Delphi-Based Recommendation Framework
1 other identifier
observational
15
1 country
1
Brief Summary
This consensus research project aims to develop standardized, evidence-based recommendations for the clinical use of skin boosters in aesthetic dermatology. Despite their widespread adoption for improving skin hydration, texture, and dermal quality, current practice patterns vary significantly across clinicians and regions, with limited unified guidelines. Using a structured Delphi methodology, the study will gather expert opinions from dermatologists and aesthetic medicine specialists to achieve agreement on key aspects of skin booster therapy, including indications, patient selection, injection techniques, dosing protocols, product selection, treatment intervals, expected outcomes, and safety considerations. The project seeks to establish practical, consensus-driven guidelines that can harmonize clinical practice, enhance treatment outcomes, and ensure patient safety. The final recommendations will serve as a reference framework for practitioners and contribute to the standardization of skin quality enhancement treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2025
CompletedFirst Posted
Study publicly available on registry
December 22, 2025
CompletedStudy Start
First participant enrolled
December 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
December 22, 2025
December 1, 2025
11 months
December 8, 2025
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Degree of Consensus on Clinical Recommendations
1. Degree of Consensus on Clinical Recommendations Definition: The level of expert agreement on each statement related to skin booster therapy. Measurement Method: Likert scale ratings (e.g., 1-9). Consensus threshold often defined as: ≥75% agreement within the 7-9 range (agreement) ≤15% ratings in the 1-3 range (disagreement) Outcome: Identification of statements that meet consensus criteria for inclusion in the final guideline. 2. Development of Final Consensus Guidelines Definition: The creation of a unified, evidence-informed set of recommendations on skin booster use. Measurement Method: Number of statements that reach consensus across all Delphi rounds. Completeness of guideline domains (indications, technique, dosing, safety, etc.). Outcome: A finalized recommendations document for clinicians.
6-12 weeks
Secondary Outcomes (1)
Implementation Readiness of Final Recommendations
6-12 weeks
Study Arms (1)
Expert Panel
A cohort of dermatology and aesthetic medicine experts participating in a Modified Delphi process to develop consensus recommendations on skin booster use.
Eligibility Criteria
The study population will consist of a purposively selected panel of experts in aesthetic dermatology and skin booster therapy. Participants will include board-certified dermatologists, aesthetic physicians, and plastic surgeons with substantial clinical experience in administering injectable skin quality treatments. The expert panel will represent a diverse range of clinical backgrounds, geographical regions, and practice settings to ensure comprehensive and balanced perspectives.
You may qualify if:
- Experts will be eligible to participate if they meet all of the following:
- Board-certified dermatologist or aesthetic physician
- With recognized qualification in dermatology, aesthetic medicine, plastic surgery, or related fields.
- Minimum clinical experience
- At least 5 years of experience performing aesthetic injectable procedures.
- OR at least 3 years of consistent use of skin boosters in clinical practice.
- Demonstrated expertise in skin booster therapy
- Must have performed ≥100 skin booster procedures overall,
- OR ≥20 sessions per year over the past 2 years.
- Active clinical practice
- Currently practicing in an aesthetic or dermatology clinic, medical center, or hospital.
- Authorship or contribution to aesthetic/dermatology education (desirable but not mandatory)
- Publications, lectures, workshop instruction, or conference involvement in aesthetics.
- Ability to participate in Delphi rounds
- Must agree to complete all survey rounds within the specified timeframe.
- +3 more criteria
You may not qualify if:
- Less than the required experience
- \<5 years of aesthetic practice
- OR insufficient hands-on experience with skin booster injections.
- Limited familiarity with skin booster products or techniques
- No regular use in the last 2 years.
- Has not performed the minimum number of required procedures.
- Industry conflict of interest
- Direct employment by a company manufacturing skin booster products.
- Significant financial relationship with a single product manufacturer that may bias responses.
- Inability to commit to multiple Delphi rounds
- Anticipated non-compliance or non-response in iterative rounds.
- Non-clinical or administrative professionals
- Those not actively practicing (e.g., retired, research-only positions, students, trainees).
- Participation in a competing guideline project
- Experts currently serving on another skin booster consensus panel to avoid duplication or bias.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Venus Research Center
Cairo, Egypt
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2025
First Posted
December 22, 2025
Study Start
December 25, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Delphi studies do not collect patient data, medical records, biological samples, or identifiable clinical information. Experts only give opinions, not "IPD." Their responses are anonymized, and sharing identifiable expert-level responses is not required and often discouraged